Skip to search formSkip to main contentSkip to account menu

SZL 49

Known as: Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(bicyclo(2.2.2)octa-2,5-dien-2-ylcarbonyl)-, SZL-49 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Review
2017
Review
2017
Background Drug-eluting balloon (DEB) has become an alternative option to drug-eluting stent (DES) for the treatment of in-stent… 
Highly Cited
1994
Highly Cited
1994
Three alpha 1-adrenergic receptors (ARs) have been cloned, i.e., the alpha 1B-, alpha 1C-, and alpha 1D-ARs. Compared with the… 
1994
1994
1 It is known that activation of α1‐adrenoceptors causes renal vasoconstriction and increased tubular Na+ and water reabsorption… 
1992
1992
Separate genes for alpha-1A and alpha-1B adrenoceptors have now been identified. Whereas alpha-1 adrenoceptors are known to… 
1990
1990
The interaction of agonists with alpha-1 receptor subtypes sensitive and resistant to alkylation by a prazosin analog [1-(4-amino… 
1989
1989
Previous studies have shown that a chemically reactive analog of prazosin, SZL-49, reduces the alpha-1 adrenoceptor population by… 
1988
1988
The effect of a newly synthesized irreversible blocker of the alpha-1 receptor [1-(4-amino-6,7-dimethoxy-2-quinazolnyl)-4-(2…